These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 1481791)
21. The use of pharmacy personnel to positively impact hospital finances. Hutchinson RA; Hatoum HT; Kolinski R; Riley DW Hosp Formul; 1989 Aug; 24(8):450, 453. PubMed ID: 10294357 [TBL] [Abstract][Full Text] [Related]
22. Hospitals vigilant for quality in pharmacy. Perry PA Hosp Mater Manage; 1989 Dec; 14(12):1-2. PubMed ID: 10296163 [No Abstract] [Full Text] [Related]
23. Alternative way to deal with nonformulary drugs. Ciezkowski J Am J Hosp Pharm; 1993 Apr; 50(4):661. PubMed ID: 8470678 [No Abstract] [Full Text] [Related]
25. As hospital drug budgets soar, pharmacy's role is being rewritten. Lumsdon K Hospitals; 1992 May; 66(10):34, 36, 38-40. PubMed ID: 1577448 [No Abstract] [Full Text] [Related]
26. Impact of a nonformulary drug notification form. Cascio MV; Williams JM Am J Hosp Pharm; 1982 Jun; 39(6):1039-41. PubMed ID: 7102687 [No Abstract] [Full Text] [Related]
27. How hospital pharmacists buckle OTCs to prescriptions via patient records. Rubin I Pharm Times; 1986 Oct; 52(10):64-6, 69. PubMed ID: 10278737 [No Abstract] [Full Text] [Related]
28. Strategies for deleting popular drugs from a hospital formulary. Lemay AP; Salzer LB; Visconti JA; Latiolais CJ Am J Hosp Pharm; 1981 Apr; 38(4):506-10. PubMed ID: 7282675 [TBL] [Abstract][Full Text] [Related]
29. How to crack the $2 billion hospital market for pharmaceuticals. Zellmer WA Med Mark Media; 1981 May; 16(5):16, 24. PubMed ID: 10251527 [No Abstract] [Full Text] [Related]
30. Impact of a pharmacist education program on nonformulary drug use. Volger BW; Ross MB; Hattle T; Rasymas A; Ryan ML Hosp Formul; 1990 Jun; 25(6):648-51, 655. PubMed ID: 10113245 [TBL] [Abstract][Full Text] [Related]
31. Achieving provider support of pharmacy benefit design. Navarro RP Med Interface; 1995 Aug; 8(8):80-1, 84. PubMed ID: 10144776 [No Abstract] [Full Text] [Related]
32. Legal issues associated with formulary product-selection when there are two or more recognized drug therapies. Liang FZ; Greenberg RB; Hogan GF Am J Hosp Pharm; 1988 Nov; 45(11):2372-5. PubMed ID: 3228094 [TBL] [Abstract][Full Text] [Related]
33. Replies to the question: should the practice of drug sampling be retained or eliminated? Hosp Formul; 1994 Oct; 29(10):720-2. PubMed ID: 10137849 [No Abstract] [Full Text] [Related]
34. Use of "dispense-as-written" on prescriptions for targeted drugs: influence of a newsletter. Ross MB; Volger BW; Bradley JK Am J Hosp Pharm; 1990 Nov; 47(11):2519-20. PubMed ID: 2278265 [No Abstract] [Full Text] [Related]
36. Pharmacist adjustment of H2-receptor antagonist dosage to meet medical staff-approved criteria. Malcolm KE; Griffin CR; Bennett TA; Robertson LM Am J Hosp Pharm; 1994 Sep; 51(17):2152-4. PubMed ID: 7985692 [No Abstract] [Full Text] [Related]
37. Three surefire ways to cut your pharmacy costs. Capitation Manag Rep; 2001 Jan; 8(1):1-7. PubMed ID: 11209215 [No Abstract] [Full Text] [Related]
38. Pharmacy practice in a small pediatric hospital. Oakley RS Am J Hosp Pharm; 1984 Apr; 41(4):694-7. PubMed ID: 6720711 [TBL] [Abstract][Full Text] [Related]
39. Initiation of a clinical pharmacology consult service as a formulary management tool. Albertson T; Musallam N; Tharratt S; Romac D; Foulke G; Mowers R; Panecek E Hosp Formul; 1993 Aug; 28(8):699-702, 707. PubMed ID: 10127748 [TBL] [Abstract][Full Text] [Related]